LIXTE BIOTECHNOLOGY HOLDINGS (LIXT)
US5393193017 - Common Stock
| 2023 (2023-12-31) | 2022 (2022-12-31) | 2021 (2021-12-31) | 2020 (2020-12-31) | 2019 (2019-12-31) | ||||
|---|---|---|---|---|---|---|---|---|
| CASH FLOWS FROM OPERATING ACTIVITIES | ||||||||
| Net Income | -5.09M | -6.31M | -6.73M | -3.26M | -2.44M | |||
| Depreciation Amortization | N/A | N/A | N/A | N/A | N/A | |||
| Change In Working Capital | 20.56K | 150.00K | -10.00K | -120.00K | 20.00K | |||
| Interest Paid | 16.23K | 10.00K | 10.00K | 0.00 | 0.00 | |||
| Taxes Paid | N/A | 0.00 | 0.00 | 0.00 | 0.00 | |||
| Other non cash items | 773.20K | 1.55M | 2.60M | 1.25M | 750.00K | |||
| OPERATING CASH FLOW | -4.29M | -4.61M | -4.14M | -2.13M | -1.67M | |||
| CASH FLOWS FROM INVESTING ACTIVITIES | ||||||||
| Capital Expenditure | N/A | N/A | N/A | N/A | N/A | |||
| Other Investing Activity | N/A | N/A | N/A | N/A | N/A | |||
| INVESTING CASH FLOW | N/A | N/A | N/A | N/A | N/A | |||
| CASH FLOWS FROM FINANCING ACTIVITIES | ||||||||
| Debt Issued/Reduced | N/A | N/A | N/A | N/A | N/A | |||
| Stock Issued/Repurchased | 3.14M | 5.14M | 3.91M | 4.60M | 0.00 | |||
| Dividend Paid | N/A | N/A | N/A | N/A | N/A | |||
| Other Financing Activity | N/A | 0.00 | -10.00K | N/A | N/A | |||
| FINANCING CASH FLOW | 3.14M | 5.14M | 3.90M | 4.60M | 0.00 | |||
| CHANGE IN CASH | -1.15M | 530.00K | -250.00K | 2.47M | -1.67M | |||
| FREE CASH FLOW | ||||||||
| Operating Cash Flow | -4.29M | -4.61M | -4.14M | -2.13M | -1.67M | |||
| Capital Expenditure | N/A | N/A | N/A | N/A | N/A | |||
| FREE CASH FLOW | -4.29M | -4.61M | -4.14M | -2.13M | -1.67M | |||
All data in USD